Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Comparison of library preparation methods reveals their impact on interpretation of metatranscriptomic data.

Alberti A, Belser C, Engelen S, Bertrand L, Orvain C, Brinas L, Cruaud C, Giraut L, Da Silva C, Firmo C, Aury JM, Wincker P.

BMC Genomics. 2014 Oct 20;15:912. doi: 10.1186/1471-2164-15-912.

2.

Role of dynamin 2 in the disassembly of focal adhesions.

Briñas L, Vassilopoulos S, Bonne G, Guicheney P, Bitoun M.

J Mol Med (Berl). 2013 Jul;91(7):803-9. doi: 10.1007/s00109-013-1040-2. Epub 2013 Apr 23. Review.

PMID:
23609221
3.

A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.

Durieux AC, Vassilopoulos S, Lainé J, Fraysse B, Briñas L, Prudhon B, Castells J, Freyssenet D, Bonne G, Guicheney P, Bitoun M.

Traffic. 2012 Jun;13(6):869-79. doi: 10.1111/j.1600-0854.2012.01348.x. Epub 2012 Apr 3.

4.

ColVI myopathies: where do we stand, where do we go?

Allamand V, Briñas L, Richard P, Stojkovic T, Quijano-Roy S, Bonne G.

Skelet Muscle. 2011 Sep 23;1:30. doi: 10.1186/2044-5040-1-30.

5.

Early onset collagen VI myopathies: Genetic and clinical correlations.

Briñas L, Richard P, Quijano-Roy S, Gartioux C, Ledeuil C, Lacène E, Makri S, Ferreiro A, Maugenre S, Topaloglu H, Haliloglu G, Pénisson-Besnier I, Jeannet PY, Merlini L, Navarro C, Toutain A, Chaigne D, Desguerre I, de Die-Smulders C, Dunand M, Echenne B, Eymard B, Kuntzer T, Maincent K, Mayer M, Plessis G, Rivier F, Roelens F, Stojkovic T, Taratuto AL, Lubieniecki F, Monges S, Tranchant C, Viollet L, Romero NB, Estournet B, Guicheney P, Allamand V.

Ann Neurol. 2010 Oct;68(4):511-20. doi: 10.1002/ana.22087.

PMID:
20976770
6.

Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern.

Deconinck N, Dion E, Ben Yaou R, Ferreiro A, Eymard B, Briñas L, Payan C, Voit T, Guicheney P, Richard P, Allamand V, Bonne G, Stojkovic T.

Neuromuscul Disord. 2010 Aug;20(8):517-23. doi: 10.1016/j.nmd.2010.04.009. Epub 2010 Jun 23.

PMID:
20576434
7.

Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.

Briñas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C.

J Antimicrob Chemother. 2005 Dec;56(6):1107-10. Epub 2005 Oct 20.

PMID:
16239288
8.

BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa.

Poirel L, Brinas L, Verlinde A, Ide L, Nordmann P.

Antimicrob Agents Chemother. 2005 Sep;49(9):3743-8.

9.

Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.

Poirel L, Brinas L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2005 Aug;49(8):3593-7.

10.

Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003.

Briñas L, Moreno MA, Teshager T, Sáenz Y, Porrero MC, Domínguez L, Torres C.

Antimicrob Agents Chemother. 2005 Mar;49(3):1262-4.

11.

Outbreak of SHV-5 beta-lactamase-producing Klebsiella pneumoniae in a neonatal-pediatric intensive care unit in Spain.

Briñas L, Lantero M, Zarazaga M, Pérez F, Torres C.

Microb Drug Resist. 2004 Winter;10(4):354-8.

PMID:
15650382
12.

Pediatric infection due to multiresistant Salmonella enterica serotype Infantis in Honduras.

Liebana E, Batchelor M, Torres C, Briñas L, Lagos LA, Abdalhamid B, Hanson ND, Martinez-Urtaza J.

J Clin Microbiol. 2004 Oct;42(10):4885-8.

13.

Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal.

Costa D, Poeta P, Briñas L, Sáenz Y, Rodrigues J, Torres C.

J Antimicrob Chemother. 2004 Nov;54(5):960-1. Epub 2004 Oct 7. No abstract available.

PMID:
15472002
14.

Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins.

Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, Torres C.

Antimicrob Agents Chemother. 2004 Oct;48(10):3996-4001.

15.

Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.

Briñas L, Moreno MA, Teshager T, Zarazaga M, Sáenz Y, Porrero C, Dominguez L, Torres C.

Microb Drug Resist. 2003 Summer;9(2):201-9.

PMID:
12820806
16.

Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens.

Briñas L, Moreno MA, Zarazaga M, Porrero C, Sáenz Y, García M, Dominguez L, Torres C.

Antimicrob Agents Chemother. 2003 Jun;47(6):2056-8.

17.

Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.

Sáenz Y, Zarazaga M, Briñas L, Ruiz-Larrea F, Torres C.

J Antimicrob Chemother. 2003 Apr;51(4):1001-5. Epub 2003 Mar 13.

PMID:
12654733
18.

Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.

Domínguez E, Zarazaga M, Sáenz Y, Briñas L, Torres C.

Microb Drug Resist. 2002 Winter;8(4):321-7.

PMID:
12523629
19.

Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C.

Antimicrob Agents Chemother. 2002 Oct;46(10):3156-63.

20.

Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain.

Sáenz Y, Zarazaga M, Briñas L, Lantero M, Ruiz-Larrea F, Torres C.

Int J Antimicrob Agents. 2001 Oct;18(4):353-8.

PMID:
11691568

Supplemental Content

Loading ...
Support Center